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THE UTILITY OF ESOPHAGOGASTRODUODENOSCOPY WITH BIOPSY IN 
DIAGNOSIS AND TREATMENT OF CHILDREN PRESENTING WITH 
FAILURE TO THRIVE  
SARA HAJIZADEH BARFJANI 
ABSTRACT 
 Introduction: Gastrointestinal pathologies are a common etiology of organic 
failure to thrive and feeding difficulties; therefore failure to thrive can be a common 
indication for esophagogastroduodenoscopy (EGD), especially in infants and young 
children. However there has been no recent studies investigating diagnostic outcome of 
EGD in children specifically with failure to thrive or feeding difficulties.   
 Aim: To investigate the outcome of EGD with biopsy in children presenting with 
failure to thrive or feeding difficulties and to determine the extent to which EGD with 
biopsy results led to a change in diagnosis or clinical management, including medication 
and nutritional supplements.  
 Methods: We performed a retrospective cohort study in children under the age of 
3 (defined as from 0 up to and including 36 months) who had been seen at one of Boston 
Children’s Hospital’s outpatient gastroenterology clinics and undergone EGD for the 
investigation of failure to thrive or feeding difficulties from 1 January 2015 to 31 
December 2015.  
Results: Poor weight gain (55.6%), gastroesophageal reflux (44.4%) and food 
refusal (38.9%) were the most common presenting symptoms at the first GI clinic visit. 
The overall prevalence of any gross endoscopic abnormality was 24.8%.  The overall 
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prevalence of any histologic abnormality was 44.2%. Compared to subjects with normal 
esophageal histology, subjects with abnormal esophageal histology had a lower 
proportion of gastroesophageal reflux and vomiting as their main presenting symptom 
(63.4% vs. 44.4%, p-value = 0.04). Compared to subjects with normal esophageal 
histology, subjects with histologic abnormalities in the esophagus were more likely to 
have current allergy to milk (25% vs. 9.6%, p = 0.02), peanut (8.3% vs. 1.1%, p = 0.03) 
and tree nut (8.3% vs. 1.1%, p = 0.03).  
 Conclusion: In this study gastroesophageal reflux was more prevalent in subjects 
with normal esophageal histologic findings than those with abnormal findings (63.4% vs. 
44.4%, p-value = 0.04). Although the largest number of histologic abnormalities were 
found in infants, infants were still more likely to have normal than abnormal histology in 
the esophagus. This finding suggests a more a careful consideration of signs and 
symptoms prior to proceeding with EGD in infants. Subjects with current milk allergy 
were more likely to have esophageal histologic abnormalities (p-value = 0.02). Further 
analysis could indicate current milk allergies as a predictive variable in esophageal 
histologic abnormalities.  
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BACKGROUND 
 
 This background section reviews: 1) the various published definitions of failure to 
thrive and feeding difficulties and their effect on prevalence studies; 2) the importance 
and common etiologies of failure to thrive and feeding difficulties; 3) the role of testing 
and specifically the importance of esophagogastroduodenoscopy (EGD) in diagnosis of 
the underlying causes of these conditions; and 4) a thorough review of the current 
literature in regards to the positive outcome of EGD to demonstrate the need for and 
importance of this study.  
 
1. Failure to Thrive and Feeding Difficulties: Definitions and Prevalence  
Failure to thrive refers to an abnormal growth pattern reflecting failure of a child 
to grow at an expected rate consistent with growth standards. It is a common concern in 
pediatrics, especially among infants and children under the age of 3, because of a 
demonstrated adverse effect on growth and cognitive development (Corbett, Drewett, & 
Wright, 1996; Kristiansson & Fallstrom, 1987). Failure to thrive results from inadequate 
nutrition and therefore it is an indication of either an underlying medical, psychosocial or 
environmental problem rather than a disease entity by itself (Gahagan, 2006).   
Feeding difficulties refers to an array of disruptive feeding behaviors that concern 
parents and physicians alike. These behaviors include: limited appetite, selective intake, 
fear of feeding (Kerzner et al., 2015) as well as delayed or absent development of feeding 
or eating skills, difficulty tolerating fluids or foodstuff, and using food as a means to self-
soothe (Bryant-Waugh, Markham, Kreipe, & Walsh, 2010). Severe feeding difficulties 
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could potentially lead to poor weight gain or malnutrition, which is subsequently 
associated with deficits in cognitive development (Reif, Beler, Villa, & Spirer, 1995), 
behavioral issues (Salt, Galler, & Ramsey, 1988) and eating disorders in adolescence 
(Marchi & Cohen, 1990).  
Though failure to thrive is commonly defined by sex-specific weight-for-age or 
weight-for-length less than 5th percentile, z-score less than -2 or growth deceleration 
across two major percentile lines, there is no consensus on its precise definition. (Cole & 
Lanham, 2011; Olsen, 2006) Various anthropometric criteria for diagnosing failure to 
thrive are shown below in Table 1.  
Table 1. Anthropometric Criteria for Diagnosing FTT. Taken from (Cole & Lanham, 2011) Various 
anthropometric criteria that are currently used in literature to define/diagnose FTT is presented here.  
Body mass index for age less than the 5th percentile 
Length for age less than the 5th percentile 
Weight deceleration crossing two major percentile lines 
Weight for age less than 5th percentile  
Weight less than 75% of median weight-for-age 
Weight less than 75% of median weight-for-length 
Weight velocity less than the 5th percentile 
 
Due to the lack of this precise definition, there are inconsistent prevalence numbers 
among existing literature.  Some studies show a prevalence of between 5-10% in children 
seen in primary care setting in the United States, 80% of which present before 18 months 
of age (Schwartz, 2000; Stephens, Gentry, Michener, Kendall, & Gauer, 2008). Schwartz 
used “deceleration of growth (in stature or weight) without strict regard to cause” as the 
definition of failure to thrive. Another study however, shows prevalence rates as high as 
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17% and 20% among infants 2-6 months and 6-11 months respectively (Olsen et al., 
2007). For inclusion in this study the subjects were only required to meet one of the 
definitions of failure to thrive listed in Table 1.    
As in failure to thrive, there is no consensus among the existing literature on a 
precise definition of feeding difficulties, therefore incidence and prevalence rates for 
feeding difficulties are also highly variable among various reports. One report by Carruth 
and colleagues indicated the percentage of caregivers who considered their child to be a 
picky eater at 4 to 6 months was 19% and increased to 50% for children 19 to 24 months 
in age (Carruth, Ziegler, Gordon, & Barr, 2004). Feeding difficulty or pickiness in this 
study was defined as children who reject certain types of food that parents perceive as 
appropriate for their age. Other reports indicated 25-45% of children and up to 80% of 
developmentally delayed children suffered from feeding problems (Lindberg, Bohlin, & 
Hagekull, 1991).  In these reports colic, vomiting and refusal to eat were used as the 
definition of feeding difficulty.   
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2. Failure to Thrive and Feeding Difficulties: Importance and Common Etiology 
There are 3 notable types of Failure to thrive: 
1. Organic– A medical disorder is an underlying issue leading to malnutrition 
2. Non-Organic– No identifiable medical condition, rather a psychosocial or 
environment issue is leading to malnutrition 
3. Multifactorial– both medical and psychosocial problems contribute to the child’s 
malnutrition 
There are 3 principal pathological mechanisms causing failure to thrive.  
1. Excessive loss of calories or reduced absorption 
2. Increased caloric expenditure 
3. Inadequate intake of calories (Gahagan, 2006) 
Various medical and psychosocial causes of failure to thrive are summarized in Table 1 
in accordance with the 3 principal mechanisms outlined above.   
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Table 2. Pathological causes of FTT. Modified from (Bergman & Graham, 2005; Shah, 2002; Susanna Y. Huh, 
September, 15 2015) A list of possible disorders that can be an underlying cause of FTT is presented in accordance to 
the 3 principal mechanisms that contribute to FTT. 
Excessive loss of 
calories or reduced 
absorption of 
nutrients 
Gastrointestinal Causes 
• Vomiting 
o Gastroesophageal reflux disease, eosinophilic 
Esophagitis, obstructios, infections  
• Malabsorption/Diarrhea or loss or damage to villous 
surface 
o Celiac disease, inflammatory bowel disease, 
pancreatic insufficiency (eg. cystic fibrosis), or 
colitis 
Neurological Causes 
• Cerebral Palsy, Hypertonia or movement disorders 
Renal Causes 
• Renal Losses 
o Renal failure/ renal tubular acidosis, diabetes 
insipidus, recurrent urinary tract infection 
 
Increased caloric 
expenditure 
• Cardiac disease 
o Congenital and acquired heart disease 
• Liver failure, renal failure, chronic pulmonary disease 
• Endocrine disorders 
o Hyperthyroidism, Hyperaldostronism, Diabetes 
mellitus  
• Metabolic disorders 
o Aminoacidopathies, Inborn error of carbohydrate 
metabolism 
• Genetic abnormality 
o Fetal Alcohol Syndrome, Smith-Lemli Optiz 
syndrome 
• Chronic Infections 
o Tuberculosis 	  
Inadequate caloric 
intake 
• Lack of appetite 
o Chronic illness, anemia or psychosocial disorder 
• Food not available 
o Type or volume of food not appropriate, feeding 
technique, parental-infant interaction problems or 
withholding of food 
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As in failure to thrive, feeding difficulties can be an indication of either an 
underlying medical, psychosocial or environmental problem. Some of the more relevant 
medical conditions to consider in children presenting with feeding difficulties include: 
structural, gastrointestinal, cardiorespiratory, neural, metabolic, food allergy and celiac 
disease. (Burklow, Phelps, Schultz, McConnell, & Rudolph, 1998) Other gastrointestinal 
conditions such as esophagitis, gastritis, gastroesophageal reflux or more prominently 
eosinophilic esophagitis (Mukkada et al., 2010) can be a root cause of pain in response to 
feeding. Thus an understanding of the relationship between presenting symptoms and the 
underlying disease could inform the diagnostic work up and medical management.  
 
Gastrointestinal Causes of FTT and Feeding Difficulties 
Among the pathological causes of failure to thrive, gastrointestinal disorders are 
the most common concern. One study indicates 40% of organic etiologies were due to 
gastrointestinal disorders (Sills, 1978).  Out of 185 patients hospitalized for evaluation of 
failure to thrive in this study, 34 had organic etiologies and 14 of those had 
gastrointestinal disorders. Another study shows 2 out of 3 patients with organic failure to 
thrive were diagnosed with either gastroesophageal reflux or non-specific chronic 
diarrhea (Berwick, Levy, & Kleinerman, 1982).  Out of the 122 infants admitted for 
evaluation of failure to thrive in this study, 38 had organic etiologies, 16 of which, had 
gastroesophageal reflux.  
As evidenced by Berkwick et al study one of the most common organic etiologies 
of failure to thrive and feeding difficulties in young children is gastroesophageal reflux. 
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(Berwick et al., 1982) In infants gastroesophageal reflux can present as non-specific 
irritability, apnea or malnutrition due to regurgitation, however it tends to resolve within 
the first 1 or 2 years of life. Gastroesophageal reflux can also be secondary to other 
esophageal disorders such as anatomic abnormalities, food allergy, GI dysmotility or 
repaired esophageal atresia. (Pathology of Pediatric Gastrointestinal and Liver Disease, 
2014) Though this condition tends to resolve in young children, there can be serious 
complications with long-standing symptoms, which include ulceration, peptic strictures, 
secondary infections and Barrett’s Esophagus.  Gastroesophageal reflux is typically 
treated with acid suppression via proton pump inhibitors or H2 receptor antagonist.  
Another common condition that has surfaced over the past two decades is 
eosinophilic esophagitis, which is thought to have an immune-mediated etiology. 
(Dellon, 2012) This condition is often associated with extraintestinal allergic symptoms 
such as asthma, eczema and chronic rhinitis. (Pathology of Pediatric Gastrointestinal and 
Liver Disease, 2014) Unlike gastroesophageal reflux, eosinophilic esophagitis does not 
respond to acid suppression, thus either a strict food elimination diet or topical swallowed 
corticosteroids are used for treatment. (Liacouras et al., 2011) Serious complications such 
as narrowing of the esophagus, significant dysphagia and development of esophageal 
strictures can occur in adolescence or adulthood if the condition is left untreated.  
Lastly, celiac disease can be a common underlying cause of failure to thrive or 
feeding difficulties. This condition is caused by an immune reaction to gluten, which is 
the major protein in wheat, barley and rye. This immune reaction can damage the 
intestinal mucosa and result in malabsorption of nutrients. Children with celiac disease 
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often present within the first 6-24 months of life with diarrhea, abdominal distention, 
vomiting and failure to thrive. (Pathology of Pediatric Gastrointestinal and Liver 
Disease, 2014) Life-long gluten free diet is the typical treatment for celiac disease.  
 
3. Role of Testing and EGD in the diagnosis and management of FTT and feeding 
difficulties 
Studies have demonstrated that in evaluation of FTT, laboratory and radiologic 
tests have little diagnostic value without an indication from history and physical 
examinations. Therefore these tests should be performed based on findings in history and 
physical examination. In a study by Sills and colleagues only 1.4% of lab tests performed 
had a positive diagnostic value. Without indications from the history and physical exam, 
no test had a predictive value. (Sills, 1978) In the study by Berwick and colleagues an 
average of 40 tests per patient was performed and only 0.8% of all test contributed to the 
diagnosis of FTT. (Berwick et al., 1982) However these studies were carried out over 30 
years ago. In the span of the past 30 years new tests have been developed and new 
diseases have surfaced. While these studies negate a shotgun approach to testing, they do 
suggest further testing if it is supported by the history and physical examination.  Figure 1 
illustrates a stepwise approach in the evaluation of failure to thrive. 
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Figure 1. Steps to consider in evaluation of FTT.  Modified from (Cole & Lanham, 2011) This figure represents 
the differential diagnosis steps involved in evaluating patients with FTT. Red flags include symptoms such as recurrent 
vomiting, specific stool patterns, family history of celiac disease, etc.  
  
In children EGDs are typically done with anesthesiologist present for inhaled 
sedation (propofol) or intubation. An EGD is performed by passing an endoscope through 
the upper gastrointestinal tract. This approach provides both a direct visual inspection of 
the esophagus, stomach, duodenal bulb and duodenum (past the ampulla of vater) and an 
opportunity to obtain tissue sample from each area for histologic evaluation. Some 
studies (Black, Haggitt, & Whitington, 1988) have demonstrated that only gross 
endoscopic visualization may miss significant mucosal abnormalities in children. Thus 
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taking multiple tissue samples during an EGD is a routine practice in Pediatrics 
Gastroenterology.  
An EGD is an important test that has the potential to make a diagnosis and change 
the management of FTT or feeding difficulties.  Clinical symptoms and signs can be 
insufficient to make certain diagnoses.  Currently EGD with biopsy is the only diagnostic 
method for some upper gastrointestinal disorders such as eosinophilic esophagitis, peptic 
ulcer due to Helicobacter pylori or celiac disease. Celiac disease affect 1 in 141 
individuals in the United States (Rubio-Tapia, Ludvigsson, Brantner, Murray, & 
Everhart, 2012), and the diagnosis of this condition would lead to a lifetime gluten-free 
diet. Prevalence of eosinophilic esophagitis in children in the US is reported as 43 in 
100,000 individuals. (Soon, Butzner, Kaplan, & deBruyn, 2013)  One study has 
demonstrated that the prevalence of eosinophilic esophagitis has increased on average by 
56% annually from 2000 to 2003. (Noel, Putnam, & Rothenberg, 2004) Diagnosis of 
eosinophilic esophagitis would lead to either a swallowed steroid therapy or a 6-food 
elimination diet in order to control the disease.  
The ability to definitively diagnose such diseases has led to an increase in the use 
of EGD over recent decades. According to a retrospective chart review conducted at 
Children’s Hospital in Philadelphia (Franciosi et al., 2010), the number of pediatric EGD 
increased twelve-fold between 1985 and 2005.  However, an EGD is not without risk, 
and it is unclear how often EGD findings change patient management. An improved 
understanding is needed of the characteristics of patients with positive EGD findings, and 
how often an EGD changes the diagnosis or management.  
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In considering whether or not to perform an EGD, a physician must balance the 
cost, diagnostic yield, and risks to the child. There are both short term and long-term risks 
associated with EGDs. Short-term risks include potential for bleeding, hypoxia, 
perforation of the intestinal mucosa, and/or infection either from perforation or from 
contaminated endoscopes.  One report indicates an immediate adverse event rate of 2.3% 
for EGD in children, including hypoxia (1.5%) and bleeding (0.3%) (Thakkar, El-Serag, 
Mattek, & Gilger, 2007). This study also indicated a higher complication rate in infants 
and younger children than those over 10 years of age. Another study indicate 42% rate of 
adverse events in patients 30 days after EGD, which includes sore throat (34%), fatigue 
(6.6%), cough (4.1%) and headache (3.3%). (Samer Ammar et al., 2003) There are also 
long-term risks associated with anesthesia. Some studies have found 2 or more episodes 
of generalized anesthesia before the age of 2 years increased the risk of learning 
disabilities (Wilder et al., 2009). Collectively these studies demonstrate that an 
assessment of current endoscopy practice is needed in order to avoid inappropriate use of 
EGD in children.  
 
4. Review of the Current Literature 
 
There are several gaps in the literature regarding the role of EGD in the diagnosis 
and management of FTT and feeding difficulties.  The few existing studies are difficult to 
generalize to this patient population because of heterogeneity in participant ages, and 
unclear definitions of FTT or feeding difficulties.  
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There is limited data on the prevalence of positive or abnormal findings for either 
gross and/or histologic findings of EGDs among infants and young children presenting 
specifically with failure to thrive or feeding difficulties.  Studying the role of EGD in 
infants and young children is important because different age groups are prone to 
different GI abnormalities. However, all except one of the current studies investigating 
outcomes of EGD (as shown in Table 3) have a wide range of age typically from 0 to 18 
years with multiple indicators, and the investigators typically did not stratify their 
findings by age. In 2013, Sheiko et al found that among 1-17 year olds undergoing EGD, 
gross endoscopic and histologic abnormalities were found in 34% and 40.4% 
respectively. (Sheiko, Feinstein, Capocelli, & Kramer, 2013) This study showed in the 95 
patients who presented with failure to thrive 20% had endoscopic abnormalities and 33% 
had histologic abnormalities, however it is unclear how many patients were under the age 
of 3 years. In 2009, Thakkar et al investigated the prevalence of abnormal gross 
endoscopic and/or histologic finding of EGD in children with chronic abdominal pain and 
found an overall yield of 38%. (Thakkar et al., 2009) In this cohort there were diagnoses 
such as crohn’s disease, Barrett’s esophagus and erosive esophagitis, which are generally 
found in children older than 3 years, and are rarely found in children under the age of 3.  
Another common issue found in current literature is a lack of clear definition for 
failure to thrive or other diagnoses such as esophagitis or gastritis. Lack of a clear 
definition complicates comparison between 2 populations. As presented earlier in Table 1 
failure to thrive can be defined in a variety of ways, and to ensure generalizability, the 
explicit definition used to include subjects needs to be clear. Other diagnoses such as 
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esophagitis and gastritis are very broad and can have multiple underlying reasons such as 
various infectious agents, caustic, reflux due to anatomic abnormality, which can result in 
different medical management for each. A precise definition would help delineate 
clinically significant inflammation of the upper GI tract from very mild or transient 
inflammatory condition. In one study, Volonaki and colleagues examined histological 
findings from a mucosal biopsy in infants under the age of 1. Their study indicated a 
63.8% overall histological abnormalities. (Volonaki et al., 2012) However this study 
failed to include a clear description of the types of findings that constitute esophagitis, 
gastritis or enteropathic abnormalities. Even though 41% of patients in this study 
underwent EGD for the indication of failure to thrive, there is no information regarding 
the number of these specific patients with positive histological findings. This study was 
also carried out over a 20-year period during which referral patterns, technical means and 
even diagnoses may have been changed. Lastly this study was focused on histologic 
abnormalities exclusively and did not take any gross endoscopic findings into account for 
the final diagnosis.  
There is also a lack of studies examining the effect of EGD on diagnosis and 
clinical management. In our review of the literature, only one study (Lee, Zainuddin, 
Boey, & Chai, 2013) examined the effect of EGD on diagnosis and treatment. Results of 
this study indicated that 22% of procedures led to a change in diagnosis, and 44% of 
procedures led to a change in clinical management. This study found that an indication of 
vomiting and abdominal pain were associated with a change in the initial diagnosis. 
However, no specific details regarding the commonly found diagnoses or change in 
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management was provided. About 50% of the EGDs performed in this study had an 
indication of variceal surveillance/eradication. Although there were relevant indications 
to the present study such as failure to thrive or gastroesophageal reflux, these indications 
were not stratified by age. This study also included an age range between 3 months-18 
years of age, which again emphasizes the paucity of data in our population of interest.  
There is a lack of agreement among different studies on predictor variables for 
positive outcome in EGD. In 2008, Noble et al identified age greater than 13, vomiting 
and hypoalbuminemia to be predictive of positive EGD results. (Noble, Drouin, & 
Tamblyn, 2008) They report vomiting as a risk factor for mucosal inflammation and 
hypoalbuminemia as predictive of colitis associated with inflammatory bowel disease, 
which is similar to other previous studies. (Holmquist, Ahren, & Fallstrom, 1989; Khan, 
Schwarzenberg, Sharp, Greenwood, & Weisdorf-Schindele, 2002) Alrazzak et al 
identified abdominal pain (Alabd Alrazzak, Husien, Preston, & Elitsur, 2014) as the most 
common referring symptom for an EGD study and predictive of positive 
histopathological outcome. Sheiko et al identified positive celiac serology, dysphagia and 
GI bleeding to be predictive of positive gross and/or histological outcome 52%, 56%, and 
57% of the time respectively (Sheiko et al., 2013).  While some of these results such as 
vomiting and dysphagia are commonly found symptoms in our patient population, others 
such as abdominal pain and GI bleeding are not as common. Thus it is difficult to 
generalize these results to our patient population. Table 4 presents a short summary of 
primary indications and findings in the existing studies in current literature.   
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Table 3. Comparison of Studies in Current Literature.  A comparison of the primary indications and findings in 
current literature investigation diagnostic yield of EGD in children is presented in this table. E = Endoscopic 
Abnormality, H = Histologic Abnormality 
Author, 
Year 
Age 
Range 
No of 
Patients 
Primary Indications Findings 
(Alabd 
Alrazzak et 
al., 2014) 
1 – 17 
years 
728 Abdominal pain- 64%  
nausea and vomiting- 
23% 
FTT- 6.4% 
GI bleeding- 6.0% 
dysphagia- 5.6% 
Gastritis = 56% 
Esophagitis = 37% 
Duodenitis = 11% 
Eosinophilic Esophagitis = 
37% 
H. Pylori = 2% 
 
(Gilger & 
Gold, 
2005) 
0 – 18 
years 
27,710 
 
12470 
were <5 
years 
Abdominal Pain – 38% 
Vomiting – 20% 
Reflux Symptoms – 
16% 
Nausea – 9% 
Weight loss – 7% 
Dyspepsia – 6% 
Dysphagia – 4% 
Mucosal Abnormalities – 
21% 
Esophageal inflammation – 
13% 
Other – 13% 
Hiatal Hernia – 4% 
Foreign Body – 3% 
Ulcer – 2% 
 
(Lee et al., 
2013) 
3 months 
– 18 years 
301 
 
35 were 
<2 years 
Esophageal varices – 
50%  
GI bleeding – 25% 
79% of EGDs resulted in 
positive finding, 44% lead to 
a change in treatment, 22% 
led to change in diagnosis 
 
(Noble et 
al., 2008) 
2 – 18 
years 
876 N/A  Primary predictors were 
age>13 (45%), vomiting 
(40%),  
hypoalbumenemia (23%) 
 
(Sheiko et 
al., 2013) 
1 month – 
18 years 
1000 
 
299 were 
<4 years 
Abdominal pain- 28.7% 
Gastrointestinal reflux- 
11.7% 
Failure to thrive- 9.5%  
Diarrhea- 8.8% 
Emesis- 8.6% 
Epigastric pain-8.5% 
Esophagitis (E=9.5%, 
H=12%) 
Eosinophilic Esophagitis 
(E=5.4%, H=7.6%) 
Other (E=2.4%, H=1.5%) 
Gastritis (E=10.4, H=21.3) 
Antral Nodularity/H.Pylori 
(E=3.7, H=2.4) 
Other (E=1.4, H=0.4) 
Duodenitis (E=4.8, H=3.5) 
Celiac (E=2.9, H=6.5) 
Other (E=2.2, H=0.5) 
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Table 4. Comparison of Studies Current Literature – Continued A comparison of the primary indications and 
findings in current literature investigation diagnostic yield of EGD in children is presented in this table. E = Endoscopic 
Abnormality, H = Histologic Abnormality 	  
Author,	  
Year	  
Age	  
Range	  
No	  of	  
Patients	  
Primary	  Indications	   Findings	  
(Thakkar et 
al., 2009) 
0 – 18 
years 
1191 Abdominal Pain  Reflux Esophagitis = 23% 
Eosinophilic Esophagitis = 
2% 
Barrett’s Esophagus = 0.4% 
Candida Esophagitis = 0.4% 
Erosive Esophagitis = 2.6% 
H.Pylori = 5% 
Peptic Ulcers = 3% 
Hiatal Hernia = 4.9% 
Celiac = 1% 
Crohn’s Disease = 0.5% 
 
(Volonaki 
et al., 2012) 
0 – 12 
months 
823	   Diarrhea: 51% (0-6 
mo.s: 60.3%; 6-12 mo.s: 
44.7%); failure to thrive: 
41.2% (no significant 
difference in age 
groups); and symptoms 
of reflux: 27.1% (0-6 
mo.s: 30.6%; 6-12 mo.s: 
22%) 
 
Esophagitis = 28% 
Gastritis = 21.3% 
Enteropathic Features = 74% 
1. Villous Atrophy 
2. Inflammatory cell 
infiltration 
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  SPECIFIC AIMS 
 
 Failure to thrive and feeding difficulties are common concerns in infants and very 
young children (Gahagan, 2006; Kerzner et al., 2015; Shah, 2002). Although organic 
etiologies underlie a small proportion of failure to thrive and feeding difficulties, several 
organic causes of these conditions are detectable only through an endoscopy.  Given the 
potential benefits of detecting treatable diseases, along with the potential risks of an 
endoscopy as outlined in the Background section above, more data are required to 
understand the characteristics of children who benefit from endoscopic diagnosis and the 
degree to which endoscopy changes management. Our review of the current literature 
(Table 4) showed that the few studies that exist about the role of EGD in children suffer 
from several limitations. These limitations include combining a wide spectrum of ages 
with failure to stratify findings by age, lack of agreement in predictive symptoms, and 
inconsistent definitions of endoscopic diagnoses, rendering it difficult to compare the 
prevalence of diagnoses across studies. 
The objective of the present study is to examine the utility of 
esophagogastroduodenoscopy with biopsy in the diagnosis and treatment of children 
presenting with failure to thrive or feeding difficulties. The specific aims are to:  
1. To describe the gross endoscopic and histologic findings among children who 
underwent first time EGDs by primary indication as well as location (esophagus, 
stomach and duodenum). 
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2. To determine the extent to which Upper GI Endoscopy results led to a change in 
diagnosis or clinical management, including medications and diet. 
 
Hypotheses:	  
1. The limited data from previous studies (Sheiko et al., 2013) suggest that one-third 
of the gross or histologic findings in this population will be abnormal  
2. Majority of new diagnoses will be Eosinophilic Esophagitis and Gastroesophageal 
Reflux Disease 
3. The rate (percentage) of abnormalities will be higher among children who present 
with feeding difficulties versus children who present with failure to thrive 
exclusively 
4. Clinical management will be changed or introduced in a minority of subjects with 
abnormal findings. 
We will examine specific aim 1 using descriptive analyses.  For specific aim 2, 
we will use multivariate logistic regression analyses to assess the relationship between 
positive gross endoscopic or histologic findings and changes in clinical management. 
By examining patterns in EGD usage and characteristics of children with positive 
EGD findings, we hope to determine the subjects and indications that are most likely to 
benefit from an evaluation by EGD.   Our findings will inform the diagnostic work up 
and medical management of young children suffering from failure to thrive or feeding 
difficulties. 
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METHODS 
 
Study Design  
  We performed a retrospective cohort study in children under the age of 3 (birth to 
36 months) who were seen at one of the thirteen Boston Children’s Hospital’s (BCH) 
outpatient gastroenterology clinics and underwent esophagogastroduodenoscopy (EGD) 
for investigation of failure to thrive or feeding difficulties from 1 January 2015 to 31 
December 2015. Each patient’s first EGD at BCH was included in the study. Boston 
Children’s Hospital Institutional Review Board approved this study on November 11, 
2013.  
 
Inclusion and Exclusion Criteria 
To identify subjects with possible failure to thrive or feeding difficulties, we used 
the i2B2 electronic research database to identify subjects seen for an initial consultation 
at one of thirteen Boston Children’s Hospital GI clinics between 1 January 2015 and 31 
December 2015, who had one or more visit diagnostic billing codes likely to be 
associated with failure to thrive or feeding difficulties.  We compiled a list of eligible 
codes from International Classification of Disease, 9th revision (ICD 9). The following 
list of diagnosis codes were utilized to build the initial dataset: 1) anorexia/ loss of 
appetite, 2) avoidant/restrictive food intake disorder, 3) Dysphagia (including the various 
phases), 4) failure to thrive, <28 days and >28 days, 5) feeding difficulties, 6) feeding 
problems of the newborn, 7) malnutrition (mild, moderate, malignant degrees) 8) 
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underweight, and 9) abnormal weight loss. A comprehensive list of the utilized ICD9 
codes is presented in Table 4.   
 
Table 4. ICD9 Codes Used to Identify Subjects with FTT or Feeding Difficulties. This is a list of ICD 9 Codes with 
associated diagnoses, used to identify subjects with FTT and feeding difficulties. 
Diagnosis ICD 9 Code 
Anorexia, Loss of Appetite 783.0 
Avoidant/Restrictive food intake disorder 307.59 
Dysphagia 787.20 
Dysphagia, Oral Phase 787.21 
Dysphagia, Oropharyngeal Phase 787.22 
Dysphagia, Pharyngeal Phase 787.23 
Dysphagia, Pharyngoesophageal Phase 787.24 
Dysphagia, Other 787.29 
Failure to Thrive, <28 days 779.34 
Failure to Thrive, >28 days 783.41 
Feeding Difficulties 783.3 
Feeding problems, Newborn 779.31 
Malnutrition, Mild Degree  263.1 
Malnutrition, Moderate Degree 263.0 
Malnutrition, Malignant (Kwashiorkor) 260.0 
Underweight 783.22 
Weight loss, abnormal 783.21 
 
For the preliminary results reported below, we used the diagnostic codes above as 
our inclusion criteria, because we were unable to obtain data for patient heights and 
weights prior to the thesis deadline. For future analyses, we will refine the patient 
population to include only subjects verified to have failure to thrive or feeding difficulties 
using our predefined criteria. We have defined failure to thrive as 1) weight-for-age 
below 5th percentile at the time of the first visit, or 2) weight-for-length z-scores of less 
than -2. We have defined feeding difficulties as presentation of one of the following 
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suggestive symptoms at the first visit: 1) food refusal lasting longer than one month, 2) 
failure to advance textures in an age-appropriate manner, 3) food selectivity or food 
neophobia, 4) vomiting right before or after a meal on more than one occasion, or 5) 
choking or gagging on food or difficulty swallowing. In order to be included in the study, 
each patient must meet one of the definitions of either failure to thrive or feeding 
difficulties.  
We excluded subjects with known gastroenterological enteropathies (i.e. celiac 
diseases) or major congenital anomalies of the gastrointestinal tract (i.e. esophageal 
atresia), because EGD in these cases serves primarily as a disease-monitoring tool. 
 
Data Collection Process  
 We collected some data from electronic databases (i2b2 / Children’s 360), 
including subject’s date of birth, weight and height/length at the time of the first visit, 
ICD 9 codes from the first visit, as well as values for laboratory tests such as blood test, 
celiac serology, food allergy tests and stool tests. We designed a data abstraction form to 
record demographic and clinical data from the electronic medical record, including the 
first Gastroenterology clinic visit’s history and physical examinations, the procedure 
notes, indications for the procedure, the pathology report, laboratory results within a 
month prior or post first visit, and follow up history and physical examinations after the 
EGD procedure. The laboratory results reviewed included blood test, celiac serology, 
food allergy tests, stool tests and modified barium swallow examination.  
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Endoscopic Findings  
From the pathology report, we recorded both gross and histologic endoscopic 
findings at 3 anatomic sites: esophagus, stomach, and duodenum.  Abnormal gross 
endoscopic findings include alterations to the mucosa (such as erythema, edema, 
erosions, friability, granularity, exudate, nodularity), ulcers, and polyps.  In the 
esophagus, we also recorded signs suggestive of eosinophilic esophagitis (such as 
furrowing, esophageal rings, longitudinal narrowing, white exudate and longitudinal 
shearing).  In the duodenum, we also recorded signs suggestive of celiac disease (such as 
flattened villi, decreased folds, notching of circular folds, thickening of mucosa or 
scalloping of circular folds). 
Abnormal histological findings included increased intraepithelial inflammatory 
cells (lympohcytes, eosinophils, or neutrophils), epithelial alterations (clusters of 
eosinophils, superficial layering of eosinophils, H. pylori bacterium, villous atrophy, 
villous blunting, crypt hyperplasia and absence of goblet and paneth cells in duodenal 
mucosa), alterations to the lamina propria (such as increased number of inflammatory 
cells, elongation or increased number of papillae and fibrosis) or submucosal lymphoid 
aggregates. 
For these preliminary analyses, we defined an abnormal gross or histologic 
abnormality as the presence of one or more of the above abnormal findings. For future 
analyses, we will examine specific clinicopathologic diagnoses, which incorporate both 
clinical and pathologic criteria. Eosinophilic esophagitis diagnosis is defined by the 
presence of 15 or more eosinophils per high-power field (HPF) with appropriate 
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accompanying clinical symptoms. (Dellon, 2012; Liacouras et al., 2011) Other diagnoses 
such as celiac disease and gastroesophageal reflux were determined based on both gross 
and histologic findings.(Pathology of Pediatric Gastrointestinal and Liver Disease, 2014) 
Inflammatory conditions such as esophagitis, gastritis and duodenitis were categorized in 
3 levels of mild, moderate and severe based on the number of inflammatory cells present.  
 
Change in Diagnosis 
Change in diagnosis in this study is defined as gross endoscopic or histological 
findings that had an influence on the final diagnosis. A change in diagnosis would only 
be considered positive if the diagnosis is suggested or confirmed by an abnormal gross 
endoscopic or histologic finding. A positive outcome could indicate one of the following: 
1. A new diagnosis based on gross and/or histologic findings of EGD 
2. A change in description of the severity of the disease 
Procedures that resulted in none of the changes mentioned above were considered as 
negative outcomes. 
 
Change in Medical Management 
 A change in medication would only be considered positive if the condition 
diagnosed due to endoscopic findings is treated by the subsequently prescribed 
medication. A positive outcome in case of change in medication could indicate one of the 
following: 
	  24 
1. A new medication is prescribed or added to the current regiment 
2. A new dosage of the medication is prescribed 
3. A medication is discontinued 
A change in diet would only be considered positive if the condition diagnosed due to 
endoscopic findings would improve by that dietary change. A positive outcome in case of 
change in diet could indicate one of the following: 
1. A new type of formula is recommended or added 
2. A food elimination diet such as gluten free, 6-food elimination diet, etc. is 
recommended 
3. A type of formula or food elimination diet is discontinued 
Procedures that resulted in none of the changes mentioned above were considered as 
negative outcomes. 
 
Statistical Analysis  
  We calculated descriptive statistics for demographic features such as age and 
gender and clinical characteristics such as initial complaint and diagnosed conditions. We 
used chi-squared tests to identify variables associated with positive endoscopic or 
histologic abnormalities. The preliminary analyses focus on comparing characteristics 
and management of subjects with abnormal esophageal histology to subjects with normal 
esophageal histology, unadjusted for potential confounders.  In future analyses, we will 
use multivariable logistic regression to assess the relationship and predictive value of 
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primary clinical indications for positive gross endoscopic or histologic finding, and to 
assess how endoscopic findings change management.  
 Descriptive statistics were performed using Microsoft Excel and all other 
statistical analyses were performed using SAS software (version 9.3).  
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RESULTS 
 
Participant Selection 
167 eligible subjects were identified as being under 3 years of age and having a 
diagnosis of failure to thrive or feeding difficulties using i2b2, whom also had an EGD 
performed as part of the diagnostic evaluation.  Of the 167 subjects, we excluded 39 
subjects because of a known GI diagnosis such as celiac disease, esophageal atresia, 
cystic fibrosis, neonatal cholestasis, pyloric stenosis and jejunal atresia.  
 Because our data collection ended Mar 1, 2016 we have completed only 
preliminary descriptive and bivariate analyses for this project.  For the bivariate analyses, 
we focused on histologic abnormalities of the esophagus because this anatomic site had 
the highest prevalence of abnormalities.  Results of preliminary analyses are presented 
below. 
 
Demographic and Clinical Characteristics 
Figure 2 displays the number of subjects stratified by sex and age. Of the 129 
subjects in this study, 61% were boys and 39% were girls, most of whom were infants 
less than 1 year old; forty-seven percent of subjects in this study presented to a GI clinic 
within the first year of age.  
	  27 
 
Figure 2 – Number of subjects stratified by age and sex - Bar graph presentation of the number of subjects (n) by 
age at the time of the first visit. 
 
The most common presenting symptoms at the first GI clinic visit were 
gastroesophageal reflux and vomiting (58.1%), poor weight gain (43.4%), food refusal 
(41.9%) and respiratory symptoms with feeds (33.3%).  Respiratory symptoms included 
suspected aspiration, coughing with feeds, wheezing, recurrent pneumonia, cyanotic 
episodes and airway congestion. 
The most common ICD 9 code used to identify the appropriate subjects were 
feeding difficulties (58.1%) and failure to thrive, >28 days (15.5%). 34 of the subjects 
had other (26.4%) ICD 9 codes which included dysphagia, feeding problems of the 
newborn, underweight, and abnormal weight loss. Review of the charts for these subjects 
showed that they met one of the definitions of failure to thrive or feeding difficulties as 
outlined in the methods section.  
Among subjects with histologic abnormalities in the esophagus, common past 
medical conditions included gastrointestinal conditions (47.2%), respiratory conditions 
(36.1%), dermatologic conditions (27.8%), and head and neck conditions (27.8%). 
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Digestive conditions included a history of gastroesophageal reflux (21.7%), diarrhea 
(6.87%), or constipation (6.87%). Other GI conditions (15.3%) included gasteroenteritis, 
dysphagia, allergic colitis, infection and hematemesis. Respiratory conditions included a 
history of aspiration (9.2%), lung infections (8.4%), or asthma (3.8%). Other respiratory 
conditions included bronchiolitis, upper respiratory tract infection, obstructive sleep 
apnea, tachypnea, chronic lung disease, respiratory syncytial virus and laryngomalacia. 
Head and neck conditions included a history of more than 2 ear infections (6.1%), 
hearing loss, micrognathia, glaucoma, or estropia. Dermal conditions mostly included a 
history of eczema or atopic dermatitis as well as paniculitis and intermittent rashes.  
Among subjects with current allergies, those with milk allergy (25%) and soy 
allergy (11.1%) had highest rate of histologic abnormalities in the esophagus. Lastly in 
subjects who used nutritional supplementation at the time of the first visit, those who 
drank cow’s milk formula (52.8%) or elemental formula (30.6%) showed the highest rate 
of histologic abnormalities in the esophagus.  
 
Indications for EGD 
The most common primary indications listed on the charts for performing an EGD 
were gastroesophageal reflux and vomiting (53.9%), feeding difficulty (21.9%), failure to 
thrive (20.3%), dysphagia (8.6%), suspected celiac disease (8.6%), and suspected 
eosinophilic esophagitis (7.0%). Subjects could have more than one primary indication 
for EGD. A complete list of the primary indication for EGD is presented in Table 5.  
 
 
	  29 
Table 5. Primary Indications for EGD -Subjects could have more than one indication for EGD  
Primary Indication for EGD N = 129 (Percent of Total) 
Gastroesophageal Reflux and vomiting 69 (53.9%) 
Feeding Difficulty 28 (21.9%) 
FTT 26 (20.3%) 
Dysphagia 11 (8.6%) 
Suspected Celiac Disease 11 (8.6%) 
Suspected Eosinophilic Esophagitis 9 (7.0%) 
Diarrhea 8 (6.3%) 
Respiratory Symptoms 6 (4.7%) 
Abdominal Pain 4 (3.1%) 
Food Allergy 3 (2.3%) 	  	  
	  
Endoscopic Findings 	  
Table 6 summarizes the prevalence of endoscopic abnormalities and histologic 
abnormalities based on anatomic location (subjects could have more than one site 
affected).  The overall prevalence of any gross endoscopic abnormality was 24.8%.  The 
overall prevalence of any histologic abnormality was 44.2%. In the esophagus and 
stomach, histologic abnormalities were more common than gross abnormalities.   
 
Table 6. Prevalence of abnormal gross and histologic abnormalities on EGD – This table shows the number of 
subjects and percentage from total participants with gross endoscopic and histologic abnormalities, categorized by 
anatomic site. Subjects could have gross endoscopic or histologic abnormalities at more than 1 site.  
Anatomic Site Gross Endoscopic 
Abnormalities 
Histologic 
Abnormalities 
 N (%) 
Esophagus 12 (9.4%) 36 (27.9%) 
Stomach 12 (9.4%) 19 (14.7%) 
Duodenum 16 (12.5%) 13 (10.1%) 
Overall Endoscopic Abnormalities 32 (24.8%) 57 (44.2%) 
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Of the 75 subjects with gastroesophageal reflux as their main presenting 
symptom, 16 (44.4%) had esophageal histologic abnormalities.  Of the 56 subjects who 
presented with FTT as their main presenting symptom, 20 (55.6%) had an esophageal 
histologic abnormality.   
Subjects with and without histological abnormalities of the esophagus were 
compared with regard to age, ICD 9 code, main presenting symptoms at the first GI visit, 
past medical history, current allergies, and nutritional supplementation at the time of the 
first visit, and results are displayed in Table 7. Among the various age groups, the highest 
rate of histologic abnormalities in the esophagus was found in children under the age of 1 
year (41.7%). Between subjects who were coded for failure to thrive or feeding 
difficulties, 21 of 36 (58.3%) subjects with abnormal esophageal histologic findings were 
coded for feeding difficulties during their first GI clinic visit. Among subjects with 
histological abnormality in the esophagus, the most common presenting symptoms at the 
first GI clinic visit were poor weight gain (55.6%), gastroesophageal reflux (44.4%) and 
food refusal (38.9%).  
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Table 7.  Relationship of Patient Characteristics to Presence of Esophageal Histological Abnormalities – 
Comparison of patient characteristics among patient with abnormal esophageal histologic findings vs. those with 
normal histology.  
   Esophageal Histological Finding  
Predictor Variable N (%) Abnormal N = 36 
Normal 
N = 93 p-value 
Age 0.06 * 
1 Year old 65 (50.4%) 15 (41.7%) 50 (53.8%) - 
2 Year old 42 (32.6%) 12 (33.3%) 30 (32.3%) - 
3 Year old 22 (17.1%) 9 (25.0%) 13 (14.0%) - 
Gestational Age     
Preterm 26 (20.2%) 4 (11.1%) 22 (23.7%) 0.16 
Full Term 75 (58.1%) 22 (61.1%) 53 (57.0%) - 
No Birth Data 28 (21.7%) 10 (27.8%) 18 (19.4%) - 
ICD 9  Code 0.96 
Feeding Difficulties (783.3) 75 (58.1%) 21 (58.3%) 54 (58.1%) - 
Failure to Thrive (783.41) 20 (15.5%) 6 (16.7%) 14(15.1%) - 
Other 34 (26.4%) 9 (25.0%) 25 (26.9%) - 
Main Presenting Symptom at First GI Clinic Visit 
Gastroesophageal Reflux 
and vomiting 75 (58.1%) 16 (44.4%) 59 (63.4%) 0.05 
Poor Weight Gain 56 (43.4%) 20 (55.6%) 36 (38.7%) 0.08 
Food Refusal/Picky 
Eater/Disruptive Feeding 54 (41.9%) 14 (38.9%) 40(43.0%) 0.67 
Chokes or gags with food 41 (31.8%) 7 (19.4%) 34 (36.6%) 0.06 
Respiratory Symptoms with 
feeds 43 (33.3%) 12 (33.3%) 31 (33.3%) 1.00 
Diarrhea 10 (7.8%) 2 (5.6%) 8(8.6%) 0.56 
Other 76 (58.9%) 19 (52.8%) 57(61.3%) 0.38 
Chi-square test and *Mantel-Haenszel Chi-Square test was used.  Results are statistically significant at P<0.05. 
  
	  32 
Table 7.  Relationship of Patient Characteristics to Presence of Esophageal Histological Abnormalities 
Continued – Comparison of patient characteristics among patient with abnormal esophageal histologic findings vs. 
those with normal histology.  
   Esophageal Histological Finding  
Predictor Variable N (%) 
Abnormal  
N = 36 
Normal  
N = 93 
p-value 
Past Medical Issue 
Gastrointestinal 54 (41.9%) 17 (47.2%) 36 (38.7%) 0.79 
Gastroesophageal 
Reflux 28 (21.7%) 8 (22.2%) 20 (21.5%) 0.93 
Diarrhea 9 (7.0%) 2 (5.6%) 7 (7.5%) 0.69 
Constipation 9 (7.0%) 2 (5.6%) 7 (7.5%) 0.64 
Cardiovascular 14 (10.9%) 4 (11.1%) 10 (10.8%) 0.73 
Head/Neck 20 (15.5%) 10 (27.8%) 10 (10.8%) 0.01 
Respiratory 48 (37.2%) 13 (36.1%) 35 (37.6%) 0.87 
Aspiration 12 (9.3%) 5 (13.9%) 7 (7.5%) 0.26 
Endocrine 6 (4.7%) 4 (11.1%) 2 (2.15%) 0.17 
Renal 6 (4.7%) 3 (8.3%) 3 (3.23%) 0.52 
Neurological 19 (14.7%) 8 (22.2%) 11 (11.83%) 0.53 
Development 24 (18.6%) 8 (22.2%) 16 (17.20%) 0.46 
Hematologic: Anemia 4 (3.1%) 0 (0.0%) 4 (4.30%) 0.20 
Dermatologic 25 (19.4%) 10 (27.8%) 15 (16.13%) 0.46 
Current Allergy 
Milk 19 (14.7%) 9 (25.0%) 9 (9.68%) 0.02 
Soy 7 (5.4%) 4 (11.1%) 3 (3.2%) 0.08 
Wheat 2 (1.6%) 1 (2.8%) 1 (1.1%) 0.48 
Peanut 4 (3.1%) 3 (8.3%) 1 (1.1%) 0.03 
Treenut 4 (3.1%) 3 (8.3%) 1 (1.1%) 0.03 
Egg 5 (3.9%) 3 (8.3%) 2 (2.2%) 0.10 
Other 4 (3.1%) 2 (5.6%) 3 (3.2%) 0.54 
Nutritional Supplementation at the Time of First Visit 
Breast Milk 19 (14.7%) 14 (38.9%) 35 (37.6%) 0.92 
Expressed Breast Milk 7 (5.4%) 1 (2.8%) 4 (4.3%) - 
Cow's Milk Formula 2 (1.6%) 19 (52.8%) 59 (63.4%) 0.13 
Soy Formula 4 (3.1%) 0 (0.0%) 12 (12.9%) 0.02 
Hydrolyzed Formula 4 (3.1%) 0 (0.0%) 2 (2.2%) 0.36 
Extensively Hydrolyzed 
Formula 5 (3.9%) 7 (19.4%) 20 (21.5%) 0.85 
Elemental Formula 4 (3.1%) 11 (30.6%) 16(17.2%) 0.08 
Chi-square test and *Mantel-Haenszel Chi-Square test was used.  Results are statistically significant at P<0.05.  
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 Subjects who were younger than 1 year of age were less likely to have histologic 
abnormalities in the esophagus than older children although the p-value did not reach 
statistical significance (p-value = 0.06). The prevalence of feeding difficulties and failure 
to thrive was similar among subjects with and without histologic abnormalities  (p-value 
= 0.96) Among the main presenting symptoms at the first GI visit, the prevalence of 
gastroesophageal reflux and vomiting was higher in subjects with normal histologic 
findings in the esophagus than among subjects with abnormal findings (63.4% vs. 44.4%, 
p-value = 0.04). Regarding past medical conditions, the prevalence of past head and neck 
conditions was higher among subjects with histologic abnormalities in the esophagus (p-
value = 0.016). Compared to subjects with normal esophageal histology, subjects with 
histologic abnormalities in the esophagus were more likely to have current allergy to milk 
(25% vs. 9.6%, p = 0.02), peanut (8.3% vs. 1.1%, p = 0.03) and tree nut (8.3% vs. 1.1%, 
p = 0.03). Though peanut and tree nut allergies show a statistically significant p-value, 
there are insufficient data points to validate the observed association. Lastly among 
subjects who used nutritional supplementation, drinking soy formula showed a 
statistically significant association with absence of histological abnormalities in the 
esophagus.  
 Subjects with histological abnormalities of the esophagus were more likely to 
have a change in diagnosis, medications and nutritional management in the follow up 
appointment; Results are displayed in Table 8.  Of the 36 subjects with abnormal 
histology in the esophagus, the procedural findings were associated with a change in 
diagnosis at follow up in 56%.  Of the 36 subjects with abnormal findings, 47% had a 
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change in medication (p-value < 0.0001), and 25% had a change in nutritional 
supplementation (p-value = 0.005) at follow-up.  An increased rate of histological 
abnormalities in the esophagus was associated with both a change in diagnosis (p-value 
<0.0001) and change in medication at follow up visit whereas histologic abnormalities 
were associated with no change in nutritional supplementation  
Table 8. Relationship of Esophageal Histological Findings to a Change in Diagnosis and Medical Management – 
In 17 cases there was no follow up appointment, thus the total is 112.  
 Histological Findings in Esophagus  
 Total Abnormal, N = 36 (%) Normal, N = 93 (%) P-value 
Change in Diagnosis at Follow-Up <0.0001 
Yes 24 20 (55.6%) 4 (4.3%)  
No 87 11 (30.6%) 76 (81.7%)  
Total 112 31 (86.1%) 80 (86%)  
Change in Medication at Follow-Up <0.0001 
Yes 22 17  (47.2%) 5 (5.4%)  
No 89 14 (38.9%) 75 (80.6%)  
Total 112 31 (86.1%) 80 (86%)  
Change in Nutritional Supplementation at Follow-Up 0.005 
Yes 22 9 (25%) 7 (7.5%)  
No 89 22 (61.1%) 74 (79.6%)  
Total 112 31 (86.1%) 80 (86%)  
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DISCUSSION 
 
 In this study gastroesophageal reflux was more prevalent in subjects with normal 
esophageal histologic findings than those with abnormal findings (63.4% vs. 44.4%, p-
value = 0.04). Presentation of symptoms at a younger age was more likely to be 
associated with histologic abnormalities, although it did not reach statistical significance 
(p = 0.06). Subjects with current milk allergy were more likely to have esophageal 
histologic abnormalities (p-value = 0.02).  
In this study’s population gastroesophageal reflux and vomiting was the most 
common presenting symptom as well as primary indication for EGD. However, the 
proportion of children with gastroesophageal reflux (~21%) did not differ between those 
with abnormal vs. normal esophageal histology. This is an interesting finding since we 
would expect gastroesophageal reflux and vomiting to be predictive of abnormal 
esophageal histology. These findings suggest presentation of these symptoms should be 
carefully factored into the decision to proceed with an endoscopy. These results are quite 
different from Nobel et al, who reported vomiting as a significant predictive variable for 
positive outcome of EGD as well as a risk factor for mucosal inflammation. Sheiko et al 
reported a 25.6% and 32.6% prevalence of histologic abnormalities for the indication of 
reflux and emesis respectively, however neither was shown to be statistically significant. 
Perhaps the heterogeneity of the patient population in these two studies could be a factor 
in the difference observed with the present study. 
Although the largest number of histological abnormalities were found in infants 
(children < 1 year old), infants less than 1 year old were still more likely to have normal 
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than abnormal histology in the esophagus.  23% of 1 year olds, 29% of 2 year olds, and 
41% of 3 year olds, showed histological abnormalities in the esophagus. Our findings are 
similar to previous prevalence rates reported in other studies, although no other studies 
compared prevalence rates in 1, 2 and 3 year olds separately. Sheiko et al found a 19.7% 
overall prevalence of histologic abnormality in all locations in subjects younger than 1 
year olds and 37.6% in 1-4 year olds. Our findings might differ from previous reports 
because of the lack of stratification by year of age and anatomic site in earlier reports.  
Among subjects with abnormal esophageal histology, milk allergy (p-value = 
0.02) and past medical history of Head and Neck Disease (0.02) were more likely to be 
present. There are no other reports of this association in the existing literature. This 
finding raises the suspicion of the association of milk allergy with the diagnosis of 
eosinophilic esophagitis, since both have an immune mediated etiology. To demonstrate 
an association more data and further analysis is required to identify the exact histological 
abnormalities associated with milk allergy and whether those abnormalities constitute a 
diagnosis of eosinophilic esophagitis. Among the past medical history of head and neck 
conditions, recurrent ear infections were the most prevalent. A more detailed look at the 
exact head and neck conditions and associated histological abnormalities in these subjects 
is required to gain a better understanding of reason for this observation. 
Lastly, histological abnormalities found in the esophagus were associated with a 
change in diagnosis (p-value = <0.0001), medication (p-value = <0.0001), and no change 
in nutritional supplementation (p-value = 0.005).  This is an expected outcome since 
EGD with biopsy can be used to definitively diagnose or rule out a number of 
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gastrointestinal conditions. These results combined with the large discrepancy between 
the prevalence of overall endoscopic abnormality 24% and overall histologic abnormality 
44% supports the practice of routine biopsies in children.  61.1% of histologic 
abnormalities did not lead to a change in nutritional supplementation. However this may 
be because children with abnormal histologic findings were previously prescribed a 
hydrolyzed or elemental formula due to food allergies, recurrent vomiting, or other 
feeding difficulties.  
 
Limitations 
 There are several limitations to the current study. This was a retrospective study, 
which is inherently limited by the information gathered in the medical records by the 
physician. It is likely that some clinical characteristics were not reported, and therefore 
underestimated in our study. Data for this study was gathered from medical records at a 
single tertiary care, large academic hospital. Therefore there may be limited applicability 
of results to other types of practices. Since the study only investigated children who 
underwent EGD for evaluation of failure to thrive or feeding difficulties, there may also 
be a possibility of selection bias in our study towards those with more prolonged 
gastrointestinal symptoms such as reflux and vomiting. 
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Conclusions and Future Directions 
In the current study, we analyzed the relationship between histologic 
abnormalities in the esophagus with predictor variables listed in Table 5. However due to 
limited time to complete this study, we did not analyze the relationship of the gross 
findings in all 3 anatomic locations (esophagus, stomach and duodenum) as well as 
histologic findings in the stomach and duodenum with the predictor variables. These 
analyses in addition to the current data will be essential to form a better understanding of 
the usefulness of endoscopy in young children with failure to thrive and feeding 
difficulties.  
Since only one year of data was included in the current study, some of the 
variables have insufficient data for a meaningful statistical analysis. We suggest 
collecting one more year of data to strengthen the statistical analysis of this study. 
Furthermore, even with another year of data we may need to combine similar categories 
and reanalyze data for statistical validity. 
Another element lacking from our current analysis is a careful consideration of 
confounders and their potential effect on the results of the study. We recognize that the 
endoscopist, the pathologist and the primary gastroenterologist who determine the gross 
EGD results, histologic results and any changes in diagnosis or management respectively 
are potential sources of confounders. Thus further analyses need to be controlled for these 
individuals’ potential effect on the results.   
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For this study to have a significant clinical implication, we need to determine the 
exact type of gross and pathological findings that are likely to lead to a change in 
diagnosis and management.  
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